To advance innovative tools for immuno-oncology research, BPS Bioscience has developed expertise in knocking out one or more proteins. Stable cell lines fully lacking target proteins were generated using CRISPR/Cas9 genome editing techniques. Some cell lines include a conditional NFAT luciferase reporter to monitor activation. Use these knockout cells to investigate your proteins of interest in immuno-oncology research or use TCR/B2M Knockout Jurkat cells to assist in your research on the development of universal CAR-T donors. Interested in a custom knockout cell line? Contact us for a quote.